Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

29 Mar 2011 12:43

RNS Number : 8280D
Lupus Capital PLC
29 March 2011
 



Lupus Capital plc ("Lupus" or the "Company")

 

Purchase of shares by the Lupus Employees' Benefit Trust

 

The Company was notified on 24 March 2011 by Sanne Trustees Limited, the Trustees of the Lupus Employees' Benefit Trust (the "Trust") that, on 24 March 2011, the Trust purchased 172,461 shares of 5 pence each in the Company ("Ordinary Shares") at a price of 143.88p per Ordinary Share.

 

Following this purchase, the Trust holds 172,461 Ordinary Shares, representing 0.13% of the Company's voting share capital being 129,840,798 Ordinary Shares.

 

 

Enquiries: 0207 976 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUPCWUPGGGB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.